Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 16Phase 4 10Phase NA 6Phase 1 5

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Endocrine 2NET 1Breast 1

Conditions

Weight Loss 2Stomach Neoplasms 2Malnutrition 2Esophageal Neoplasms 2Pituitary Neoplasms 1Periampullary Tumors 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Neoplasms 1Lymphocele 1Endocrine System Diseases 1Duodenal Neoplasms 1Breast Neoplasms 1Acromegaly 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Octreotide × Clear all
NCT02381249 2023-11-27

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

St. James's Hospital, Ireland

Phase NA Completed
40 enrolled
Gastrointestinal

Duodenal Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

NCT02385617 2023-11-27

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

St. James's Hospital, Ireland

Phase NA Completed
20 enrolled
Gastrointestinal

Endocrine System Diseases, Esophageal Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

NCT06080204 2023-10-18

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Changhai Hospital

Phase NA Completed
411 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumor G2

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated
4 enrolled
Breast

Breast Neoplasms, Lymphocele

NCT02920567 2016-09-30

Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion

Saint Vincent's Hospital, Korea

Phase NA Unknown
282 enrolled

Periampullary Tumors

NCT01029275 2014-07-31

SAPORO

University Hospital, Rouen

Phase NA Completed
89 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡